Log in | Join Free | china | japan | germany
ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >Tofacitinib Impurity 69

Tofacitinib Impurity 69

Request For Quotation
Tofacitinib Impurity 69 Suppliers list
Company Name: ShenZhen H&D Pharmaceutical Technology Co., LTD
Tel: +8618627948422
Email: sale@hdimpurity.com
Products Intro: Product Name:Tofacitinib Impurity 69
Purity:0.98 Package:10mg;|25mg;|50mg
Company Name: Shenzhen SUNGENING Bio-Medical Co., Ltd.  
Tel: 0755-28967200 13631290199
Email: wxf@sungening.com
Products Intro: Product Name:Tofacitinib Impurity 69
Purity:99% HPLC or More Package:10MG;25MG;50MG;100MG
Company Name: Cato Research Chemicals Inc.  
Tel: 020-81215950 4000-868-328
Email: customer@uwalab.com
Products Intro: Product Name:Tofacitinib Impurity 69
Purity:95%（HPLC） Package:10mg；25mg；50mg；100mg
Company Name: Changzhou Xianglong Pharmaceutical Technology Co., LTD  
Tel: 0519-88910898; 18661161657
Email: yaoxiangqiu2021@163.com
Products Intro: Product Name:Tofacitinib Impurity 69
Purity:95% Package:10mg;25mg;50mg;100mg
Company Name: Hubei Moco Chemical Co., Ltd.  
Tel: 18627923403
Email: 3001039764@qq.com
Products Intro: Product Name:Tofacitinib Impurity 69
Purity:95% HPLC Package:25mg;50mg;100mg;250mg;500mg

Tofacitinib Impurity 69 manufacturers
Tofacitinib Impurity 69 Basic information
Product Name:Tofacitinib Impurity 69
Synonyms:Tofacitinib Impurity 69
CAS:
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Tofacitinib Impurity 69 Structure
Tofacitinib Impurity 69 Chemical Properties
Safety Information
MSDS Information
Tofacitinib Impurity 69 Usage And Synthesis
Tofacitinib Impurity 69 Preparation Products And Raw materials
Tag:Tofacitinib Impurity 69 Related Product Information
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) (3R,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanoic acid Carbamic acid, [(3R,4R)-4-methyl-3-piperidinyl]-, 1,1-dimethylethyl ester (9CI) (3S,4S)-Tofacitinib 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine N-methyl-N-((3S,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile 3-Piperidinamine, 1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethyl-, (3R,4R)- N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile 2,4-DICHLORO-7H-PYRROLO2,3-DPYRIMIDINE Tofacitinib Impurity 6